Literature DB >> 2693047

Influence of the degree of control of diabetes on the prevention, postponement and amelioration of late complications.

B R Zimmerman1.   

Abstract

The relationship between hyperglycaemia and the chronic complications of diabetes has been disputed for many years. Some physicians believe that the evidence that hyperglycaemia is the primary determinant of the chronic complications is convincing; others believe the question remains unsettled. Several types of study provide information. In vitro and in vivo studies demonstrate biochemical alterations induced by hyperglycaemia which could lead to structural changes and diabetic complications. Animal models demonstrate that the complications develop with induction of hyperglycaemia and are ameliorated when blood glucose is returned toward normal. Many uncontrolled clinical studies demonstrate an association between diabetes control and complications but cannot prove causality. Controlled clinical trials have sometimes, but not always, shown functional changes suggestive of amelioration of complications with control of hyperglycaemia. A definitive clinical trial has not yet been completed. Pancreas transplantation has the potential of completely normalising blood glucose, but studies to date have been limited by small numbers of patients, the advanced state of complications, and the lack of adequate controls. On balance, the evidence is highly suggestive that hyperglycaemia is a major determinant of the chronic complications of diabetes. Even if the relationship is established, the risk involved in treatment programmes to achieve near normoglycaemia must be better defined so that potential risk versus benefit can be evaluated in the individual patient when making treatment decisions.

Entities:  

Mesh:

Year:  1989        PMID: 2693047     DOI: 10.2165/00003495-198938060-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  56 in total

1.  Importance of control of diabetes in prevention of vascular complications.

Authors:  N R KEIDING; H F ROOT; A MARBLE
Journal:  J Am Med Assoc       Date:  1952-11-08

2.  Intercapillary Lesions in the Glomeruli of the Kidney.

Authors:  P Kimmelstiel; C Wilson
Journal:  Am J Pathol       Date:  1936-01       Impact factor: 4.307

3.  Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study.

Authors:  G Solders; H Wilczek; R Gunnarsson; G Tydén; A Persson; C G Groth
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

4.  The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.

Authors: 
Journal:  Diabetes       Date:  1986-05       Impact factor: 9.461

5.  Effects of intensified insulin treatment on various lesions of diabetic retinopathy.

Authors:  O Brinchmann-Hansen; K Dahl-Jørgensen; K F Hanssen; L Sandvik
Journal:  Am J Ophthalmol       Date:  1985-11-15       Impact factor: 5.258

6.  Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.

Authors:  P J Dyck; B R Zimmerman; T H Vilen; S R Minnerath; J L Karnes; J K Yao; J F Poduslo
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

7.  Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group.

Authors: 
Journal:  Diabetes Care       Date:  1987 Jan-Feb       Impact factor: 19.112

8.  Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure.

Authors:  A Teuscher; H Schnell; P W Wilson
Journal:  Diabetes Care       Date:  1988-03       Impact factor: 19.112

9.  Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study.

Authors:  I Mühlhauser; I Bruckner; M Berger; D Cheţa; V Jörgens; C Ionescu-Tîrgovişte; V Scholz; I Mincu
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

Review 10.  NIH conference. Aldose reductase and complications of diabetes.

Authors:  D G Cogan; J H Kinoshita; P F Kador; G Robison; M B Datilis; L M Cobo; C Kupfer
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

View more
  3 in total

Review 1.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 2.  Preventing long term complications. Implications for combination therapy with acarbose.

Authors:  B R Zimmerman
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 3.  Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus.

Authors:  J W Steele; D Faulds; K L Goa
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.